Pharmaceutical lobbying under postcommunism: universal or country-specific methods of securing state drug reimbursement in Poland?

Pharmaceutical lobbying under postcommunism: universal or country-specific methods of securing state drug reimbursement in Poland?

Item
http://www.wikidata.org/entity/Q37912288
Dabigatran - a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs.HTA Implementation Roadmap in Central and Eastern European Countries.Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?Physicians' knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature.The European Union Joint Procurement Agreement for cross-border health threats: what is the potential for this new mechanism of health system collaboration?Reflecting on 'European policymaking on the tobacco advertising ban: the importance of escape routes'.A DECADE OF HEALTH TECHNOLOGY ASSESSMENT IN POLAND.Polish physicians' cooperation with the pharmaceutical industry and its potential impact on public health.Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics.Transparency in practice: Evidence from 'verification analyses' issued by the Polish Agency for Health Technology Assessment in 2012-2015.Who's afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic.The persistence of cliques in the post-communist state. The case of deniability in drug reimbursement policy in Poland.
P2860

Pharmaceutical lobbying under postcommunism: universal or country-specific methods of securing state drug reimbursement in Poland?

Item
http://www.wikidata.org/entity/Q37912288
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmaceutical lobbying under ...... drug reimbursement in Poland?
@en
Pharmaceutical lobbying under ...... drug reimbursement in Poland?
@nl
type
label
Pharmaceutical lobbying under ...... drug reimbursement in Poland?
@en
Pharmaceutical lobbying under ...... drug reimbursement in Poland?
@nl
prefLabel
Pharmaceutical lobbying under ...... drug reimbursement in Poland?
@en
Pharmaceutical lobbying under ...... drug reimbursement in Poland?
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Pharmaceutical lobbying under ...... drug reimbursement in Poland?
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698